INTRODUCTION
The changing incidence and epidemiology of bacteraemia in the United States have been reported many times [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . In 1983, Weinstein and his colleagues published a comprehensive review in which the laboratory, epidemiological and clinical aspects of bacteraemia in a large population in the United States were analysed [15, 16] . Large studies in the United Kingdom have concentrated on bacteraemia caused by specific micro-organisms [17, 18] and the only major survey to come from this country is that prepared by the Communicable Disease Surveillance Centre on data submitted between 1975 and 1980 [19] .
There is therefore a shortage of British data on bacteraemia and it was decided to undertake a comprehensive review in order to provide a United Kingdom perspective on this problem. We therefore report an analysis of 875 episodes of bacteraemia and candidaemia encountered in Nottingham hospitals between January 1980 and December 1983.
MATERIALS AND METHODS
Full details of patient history, antibiotic treatment and other relevant information were recorded for all cases of bacteraemia and candidaemia diagnosed by blood culture in the Public Health Laboratory, University Hospital, Nottingham, between January 1980 and December 1983. Information was obtained by discussion with the clinician managing the case and from the case notes.
Blood culture
The same method was used throughout the study. Two bottles were used for each test, one containing laboratory-formulated liver digest broth, the other containing tryptone soya broth; each contained 0.03 per cent sodium polyanetholsulphonate in 50 ml of broth. In adults, 10 ml of venous blood was aseptically distributed between the two-bottle set, which was then taken to the laboratory for immediate incubation at 37°C. After eight to 20 h incubation (i.e. the following morning), the bottle containing liver digest broth was vented and 10 ml of the bloodbroth mixture was transferred to a brain-heart infusion agar slant; a few drops were also used to prepare a Gram-film. The bottle containing tryptone soya broth remained unvented. Broths and slants were examined visually each day for seven days; Gram-films were made on those showing evidence of growth and subcultures were made on to appropriate media for aerobic and anaerobic incubation. Cultures yielding no visible growth after seven days were also subcultured aerobically and anaerobically before being discarded. Exceptionally, blood cultures were incubated for 14 days if there was a strong clinical suspicion of endocarditis. In cases in which Haemophilus influenzae infection was suspected, an additional subculture was made after 18 to 48 h incubation on to chocolate agar.
The significance of isolates was judged according to the number of positive blood cultures, by the clinical findings, and by the results of cultures from other body sites. Organisms which are commonly recovered from the environment or skin and were regarded as highly improbable causes of the clinical state of the patient were classed as 'contaminants'.
Organisms were identified by standard methods [20] . Antimicrobial susceptibility testing was carried out by the agar incorporation technique [21] .
Definitions
Episode. Each instance of bloodstream invasion by one organism or more was defined as an episode. If seven or more days separated one episode from a preceding one, it was considered a new episode.
Community and hospital-acquired infection.
An episode was considered to be communityacquired if the first positive blood cultures were obtained within 48 h of the patient's admission, unless it was clearly related to a procedure after admission. Bacteraemia occurring on or after the third day of admission was considered hospital-acquired except in those few patients with infective endocarditis or ascending cholangitis in whom there was a delay in taking blood cultures. Neonates found to be bacteraemic while still in hospital were considered to have hospital-acquired infection.
Source. The source of bacteraemia was defined as clinically known if there was an obvious focus of infection, and culturally confirmed if the same organism was isolated from blood and from a local site of infection.
Antimicrobial treatment. Treatment was considered appropriate if the infecting organism was susceptible in vitro to any component of the antibiotic regimen used. If more than one organism was present, treatment was deemed appropriate only when all were susceptible to at least one of the antibiotics used. Treatment was considered inappropriate if any organism was resistant in vitro, or if the treatment was considered to be unacceptably inferior to that recommended by standard guides to practice [21] .
The outcome of antimicrobial treatment was analysed according to whether it was started on the same calendar day on which the positive blood culture was taken ('prompt treatment'), later ('delayed treatment'), or not given at all [22] . The comparative efficacy of monotherapy and combination therapy was studied in cases of Gram-negative bacteraemia, caused by single species of bacteria.
Outcome. Death within seven days of the first positive blood culture was considered to be directly due to bacteraemia, unless there was strong clinical evidence to the contrary. Death later was judged not directly due to bacteraemia, although the bacteraemia may have contributed in some of these cases. Patients were deemed to have 'survived' if they were discharged from hospital, transferred to another institution, or remained alive in hospital for at least three months.
Clinical variables.
The highest recorded temperature, total leucocyte and granulocyte counts were recorded on the day of the positive blood culture.
Shock was defined as a decrease in systolic blood pressure to 90 mmHg or less in a previously normotensive adult, except in those patients who were obviously bleeding from any site. The underlying disease was categorised, as described in other studies [1, 2, 5, 9, 14] as rapidly fatal (adults with acute leukaemia or with blastic relapse of chronic leukaemia), ultimately fatal (disease likely to be fatal within five years), non-fatal (disease unlikely to be fatal within five years), and none (previously fit).
Statistical analyses
All statistical analyses were carried out by the j 2 test with Yates' correction where necessary.
RESULTS
During the four-year period of the study, 25 066 sets of blood cultures were examined; 1782 (7.1 per cent) yielded a significant growth of micro-organisms, representing 933 episodes of bacteraemia in 857 patients. A further 1540 (6.1 per cent) of the blood cultures were considered to be contaminated.
Incidence P. Ispahani and others
In the same period 165414 patients were admitted to University Hospital Nottingham and three smaller hospitals served by Nottingham Public Health Laboratory. The overall incidence of bacteraemia for University Hospital alone was 7.1 episodes per 1000 admissions. Case notes of 49 patients (58 episodes) could not be traced and these were excluded from analysis. Of the remaining 875 episodes (808 patients), 814 were caused by a single microbial species and 61 by more than one microbial species. The distribution of species and the proportion of Gram-positive to Gram-negative organisms isolated from monomicrobial episodes (mean 37:63, range 33:67 to 40:60) did not change significantly from year to year.
Patients
Of the 875 episodes, 455 occurred in male and 420 in female patients; the mean age was 53.8 years. Of the 808 patients, 49 (6.1 per cent) had more than one episode of bacteraemia. Figure 1 shows the distribution of bacteraemic episodes and associated mortality according to patient age. After the age of 10 years the incidence of bacteraemia remained low, but rose sharply in older patients; 56.8 per cent (497 episodes) of all bacteraemias occurred in patients over 60 years of age.
Overall mortality was 28.8 per cent, but mortality directly related to infection was 19.5 per cent. It was lowest (4.7 per cent) in infants and young children up to the age of 10 years, and highest (25.6 per cent) in those over 60 years of age. Mortality not directly related to bacteraemia showed a steady increase with age. There was no significant difference in mortality between males (18.7 per cent) and females (20.5 per cent). 
Place of acquisition of bacteraemia
Of the 875 bacteraemic episodes, 518 (59.2 per cent) were considered community-acquired (Fig. 2) . 
Organisms
The distribution of organisms in community and hospital-acquired bacteraemia and associated mortality is shown in Table 1 . Escherichia coli was by far the commonest isolate followed by Staphylococcus aureus and Streptococcus pneumoniae.
Death directly related to bacteraemia was commoner in patients infected with Gram-positive organisms than in those with Gram-negative organisms (23.5 vs. 15.8 per cent). Bacteraemia caused by more than one organism had a worse prognosis than monomicrobial bacteraemia (31.1 vs. 18.7 per cent mortality) and patients who suffered multiple bacteraemic episodes fared less well than those who had a single episode (34.7 vs. 20.3 per cent mortality). Patients admitted to medical (38.6 per cent), surgical (22 per cent) or paediatric (12.3 per cent) units accounted for almost three-quarters of all bacteraemic episodes (Table 2) . Substantial differences were noted in the distribution of organisms on different units: bacteraemia with Grampositive organisms account for 45 per cent of episodes on medical units compared with 19.8 per cent on surgical wards; bacteraemia on paediatric units was predominantly caused by H. 
Source
The urinary tract was the commonest source of bacteraemia, followed by the respiratory tract, the gastrointestinal tract and biliary tract. In 9.7 per cent of bacteraemic episodes the focus of infection could not be identified with certainty (Table 3) . Cultural confirmation of the suspected focus of infection was achieved in 49 per cent of cases. In 26.5 per cent of cases in which the biliary tract was the presumed site, infection was due to more than one organism.
Mortality was high when the primary focus lay within the respiratory, biliary or gastrointestinal tracts, the skin and soft tissue, and in cases in which the source could not be identified. 
Antimicrobial treatment
In 79 (9 per cent) of 875 bacteraemic episodes, no antimicrobial treatment was prescribed: 22 patients died soon after admission; in 15 patients the prognosis was too poor for further active management; three patients were transferred to other hospitals; and in 39 episodes the symptoms were short-lived and self-limiting. Antimicrobial treatment was started on the day that positive blood cultures were first obtained ('prompt treatment') in 595 of the remaining 796 episodes. In evaluating 'prompt treatment', patients who received delayed, or no antimicrobial treatment were grouped together ( Table 4 ). The number of cases in the rapidly fatal group was too small for analysis, but the proportion of patients in the three remaining categories who received prompt treatment was similar (64-74 per cent). Overall, the choice of prompt treatment was 'appropriate' in 474 of 595 (79.7 per cent) episodes of bacteraemia, and was evenly distributed among the disease categories. The reduction in mortality noted in the groups who received appropriate, prompt treatment was not statistically significant.
Irrespective of the underlying disease, initial use of an appropriate agent was associated with lower mortality whether or not the treatment was prompt or delayed (Table 5 ). However, 73 of 121 patients given prompt but inappropriate treatment were subsequently changed to appropriate treatment. Of 60 patients who received inappropriate treatment throughout their illness, 19 (31.7 per cent) died as a direct result of bacteraemia, whereas, of 736 patients who were at some time treated with appropriate agents 115 (15.6 per cent) died (p<0.01). Death occurred within 48 h in 10.2 per cent of patients given prompt treatment, in 7 per cent of those given delayed treatment, and in 35.4 per cent of those given no antimicrobial treatment.
Mortality in 201 patients who received a single, appropriate antimicrobial agent for monomicrobial episodes caused by the enterobacteria (other than Salmonella spp.) and Pseudomonas spp., was not significantly different from that of a group of 92 patients who received a potentially synergistic combination, such as a/?-lactam antibiotic plus an aminoglycoside (14.9 vs. 19.6 per cent). 
Clinical variables
Fever. Failure to achieve an adequate febrile response (<38°C) was associated with increased mortality (Table 6) ; 17 of 28 patients whose temperature did not rise above 36°C died.
Shock was seen in 119 of 611 episodes (19.5 per cent) of bacteraemia. Death directly related to bacteraemia was four times as common in patients with evidence of shock than in normotensive individuals (Table 7) . Among patients infected with Gram-negative organisms the incidence of shock was high with E. coli Q2.2 per cent) and Ps. aeruginosa (21.7 per cent). Bacteraemic episodes with haemolytic streptococci were associated with the highest incidence of shock (30.0 per cent), but amongst the more common Gram-positive organisms e.g. Staph. aureus (13.8 per cent) and Str. pneumoniae (8.1 per cent), it was comparatively low. Shock among patients who had anaerobic bacteraemia was also low (8.5 per cent). Although the overall incidence of shock was lower with Gram-positive (13.4 per cent) than with Gram-negative (19.7 per cent) organisms (p<0.05), mortality directly due to bacteraemia was highest with Gram-positive organisms (88.9 vs. 49.3 per cent; p<0.05).
The incidence of shock was significantly higher in polymicrobial than in monomicrobial episodes (42.9 vs. 17.4 per cent; p<0.001) but mortality amongst those who were shocked was not significantly different in the two groups (47.4 vs. 60.2 per cent). In contrast mortality was higher in polymicrobial than in monomicrobial episodes (25 vs. 13.6 per cent) among patients who were not shocked.
Leucocytes. Mortality was highest when the total leucocyte count was lower than 4009/^1 or higher than 50000/^1 and/or when the circulating granulocyte count was less than }0O0/ft\ .4) 2 (5.1) 45 (9.1) * Significantly different from those whose total leucocyte count was between 11000 and 19999//il; p<0.001. t Significantly different from those whose granulocyte count was >1000///l;p<0.01. * Significantly different from those considered previously fit; p<0.05. t Significantly different from those considered previously fit; p<0.001. (Table 8 ). Mortality was high in patients with total leucocyte counts below 4000//^l whether or not there was an underlying haematological or other malignancy.
Underlying disease. About a third of all episodes of bacteraemia occurred in patients who were previously fit and mortality was lowest in this group (Table 9) . Mortality in patients with a rapidly, or ultimately fatal underlying disease was about fourfold higher than in the previously fit, and about twice as high as in patients with non-fatal underlying disease.
DISCUSSION

Laboratory and epidemiological findings
Experience of bacteraemia varies with the type of hospital and distribution of services [3, 6, 7, 15] . University Hospital Nottingham is a new teaching hospital with 1450 beds, of which 1043 were in use by the end of 1983. In 1980, when this survey was started, units dealing with general medicine and surgery, paediatrics, urology, orthopaedics and oncology were operational; obstetric, gynaecology and neonatal units were commissioned in November 1981. Eighty-four per cent of all cases of bacteraemia in this study originated in patients in University Hospital Nottingham, in which the incidence of bacteraemia was 7.1 per 1000 admissions, similar to that reported from other teaching hospitals in the United Kingdom [23, 24] , but much lower than rates of 12.5 to 28.0 per 1000 admissions for large city and university hospitals in the United States [3, 15] .
The preponderance of community-acquired bacteraemia is in keeping with experience in small community hospitals [6, 7] but not large teaching hospitals [3, 9, 15] in the United States. It will be interesting to see whether the proportions observed in University Hospital Nottingham change in the future. Mortality was higher in hospital-acquired than in communityacquired bacteraemia. However, in contrast to the observation of Weinstein etal. [16] , this was due to a higher incidence of indirect mortality in hospital-acquired bacteraemia, rather than any difference in direct mortality.
In our study, as in previous reports [15, 19, 25] E. coli, Staph. aureus and Str. pneumoniae accounted for nearly half of all positive blood cultures. The incidence of anaerobic organisms was low (4.9 per cent) compared with reports from elsewhere of 9.2 per cent [25] and 16.2 per cent [15] . Other workers have noted a recent fall in the incidence of bacteraemia due to Bacteroides spp., perhaps because of increased use of metronidazole as a prophylactic agent during gastrointestinal and gynaecological surgery [19] . The relatively high incidence of H. influenzae that we found reflects a busy paediatric unit in which H. influenzae accounted for over 40 per cent of all blood culture isolates.
Analysis of mortality data revealed few surprises. Mortality was higher in patients with Gram-positive than with Gram-negative bacteraemia [7, 26] , and in keeping with earlier reports [4, 5, 9, 15, 22] mortality in Gram-negative infection was most commonly associated with Ps. aeruginosa or the recovery of more than one organism in blood culture. The outcome in patients who develop several episodes of bacteraemia has received little attention in the past. The finding that mortality was increased in 49 such patients is in agreement with one previous report [5] . Most studies have found that the urinary tract is the principal source of bacteraemia [2, 6, 7, 9, 15, 22, 25] , but differences in hospital population and in the definition of 'source' make comparisons with other studies difficult. However, the increased frequency with which the biliary tract was found to be the source of bacteraemia in general, and polymicrobial episodes in particular, suggests that experience in the United Kingdom is different from that in the United States [2, 9, 15] . Evidence collected over a 10-year period by the Communicable Disease Surveillance Centre showed that the biliary tract was the suspected source of infection in approximately 12 per cent of cases of bacteraemia caused by E. coli [19, 27] . A recent study [28] revealed a polymicrobial flora in the infected bile of 20 of 23 patients with acute suppurative cholangitis; bacteraemia was seen in 10 of 12 patients in whom blood culture was performed, and was polymicrobial in three patients.
The comparatively low mortality observed when the heart valve was the source of infection may have been influenced by the decision to consider those transferred to other hospitals to have 'survived'.
Antimicrobial treatment
We attempted to correlate the choice of treatment and the timing with outcome. The apparent lack of advantage of starting treatment as soon as positive cultures are obtained was surprising, but has also been noted by others [22] . The reason for the anomaly may be that patients receiving prompt treatment were more seriously ill than those in whom treatment was delayed. High-density bacteraemia is known to be associated with high mortality [2, 9] and many of these patients die despite prompt and vigorous antimicrobial treatment [22] . Moreover, the situation might be aggravated by the release of endotoxin from Gram-negative organisms with the use of potent bacteriolytic agents [29] . A prospective clinical study to evaluate the importance of liberated endotoxin and other bacterial products would help to elucidate this problem.
Whatever the reason for the lack of impact of prompt treatment on mortality, a significant reduction in mortality was evident in patients treated with appropriate antimicrobial agents and this underlines the importance of establishing a precise microbiological diagnosis in bacteraemia.
The use of combinations of various antimicrobial agents for 'synergistic' activity has become common in clinical practice, particularly in patients who are immunocompromised [30] . Despite the demonstration of superiority of such combination therapy over a single agent in experimental Ps. aeruginosa infections in animals [31, 32] , and in some human studies [33, 34] , there are no prospective randomised studies of combination therapy versus single agent in human infections with Gram-negative bacillary bacteraemia. Retrospective analyses however, have failed to show any benefit for combination therapy [35, 36] , and we confirm this finding.
Clinical variables
Several workers have, like us, noted a higher mortality in those who failed to achieve an adequate febrile response [14, 16, 35] . However, others [2, 37] have failed to demonstrate such an effect.
The incidence of shock in Gram-negative bacteraemia appears to have declined in the last 15 years from about 40 per cent [2, 35] to about 20 per cent [16, 22] . The reduction, which we confirm, may reflect better supportive treatment and early use of empiric broad-spectrum antimicrobial therapy in the critically ill.
Information on the incidence of shock in bacteraemia caused by Staph. aureus and Str. pneumoniae remains scanty [38] , and even less is known about shock associated with /?-haemolytic streptococci. Henkel et al. [39] and Weinstein et al. [16] found 18 to 20 per cent of shock in patients with Group A haemolytic streptococci, and our observation that shock associated with haemolytic streptococci was more common than with any other group of bacteria is surprising.
The risk of acquiring infection increases progressively with the duration and magnitude of neutropenia, and recovery from bacteraemia in patients with a low white cell count is dependent on improvement in the granulocyte count during antibiotic treatment [36, 40, 41] . Thus, the high mortality observed in neutropenic patients in this series and others [2, 4, 16, 35] was not unexpected.
